Every VIEKIRA moment starts with a conversation.

For genotype 1 (GT1) chronic hepatitis C (hep C), taken with or without ribavirin

Actual VIEKIRA Patient

Talking to your doctor about VIEKIRA.

A visit to your doctor can go by fast. Being organized can be a big help. You may want to start by telling your doctor how important getting treatment is to you. Then you can move on to asking about treatment with VIEKIRA.

Use the questions from our Doctor Discussion Guide to start a more productive conversation with your doctor.

  • I read that hep C is a silent disease. Is it damaging my liver right now?
  • What is my viral genotype? Will VIEKIRA work with my genotype?
  • I’ve tried treating my hep C with interferon and ribavirin in the past, but it wasn’t successful. Could VIEKIRA work for me?
  • Are there side effects of treatment with VIEKIRA?
  • If I have other medical conditions, is VIEKIRA still right for me?
  • I saw that I could pay as little as $5 for VIEKIRA.* Am I eligible?
  • If not, do I have other options that can help me pay for treatment?

Download Doctor Discussion Guide


*Eligibility: In Massachusetts, co-pay assistance is not available for products with certain generic equivalents (for example, any product with an AB-rated generic equivalent). Available to patients with commercial prescription insurance coverage for an FDA-approved AbbVie product for treatment of hepatitis C virus. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, the patient will no longer be able to use the AbbVie HCV Co-pay Card and the patient must call PSKW at 1-844-865-8725 to stop participation. Patients may not seek reimbursement for value received from the AbbVie HCV Co-pay Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.

Learn facts about hep C

Arm yourself with information about chronic hep C.

See more

Pay as little as $5 for your VIEKIRA copay*

*Eligibility restrictions apply.

See more


IMPORTANT SAFETY INFORMATION

When taking VIEKIRA XR in combination with ribavirin, you should read the Medication Guide that comes with ribavirin, especially the important pregnancy information.

What is the most important information I should know about VIEKIRA XR?

  • VIEKIRA XR may cause severe liver problems, especially in people with certain types of cirrhosis. These severe liver problems can lead to the need for a liver transplant, or can lead to death.
  • VIEKIRA XR can cause increases in your liver function blood test results, especially if you use ethinyl estradiol-containing medicines (such as some birth control products).
    • You must stop using ethinyl estradiol-containing medicines (combination birth control pills or patches, such as Lo Loestrin® FE, Norinyl®, Ortho Tri-Cyclen Lo®, Ortho Evra®; hormonal vaginal rings such as NuvaRing®; and the hormone replacement therapy medicine, Fem HRT®) before you start treatment with VIEKIRA XR. If you use these medicines as a method of birth control, you must use another method during treatment with VIEKIRA XR, and for about 2 weeks after you finish treatment with VIEKIRA XR. Your doctor will tell you when you may begin taking ethinyl estradiol-containing medicines.
  • Your doctor should do blood tests to check your liver function during the first 4 weeks of treatment and then as needed.
  • Your doctor may tell you to stop taking VIEKIRA XR if you develop signs or symptoms of liver problems. Tell your doctor right away if you develop any of the following symptoms, or if they worsen during treatment with VIEKIRA XR: tiredness, weakness, loss of appetite, nausea, vomiting, yellowing of the skin or eyes, color changes in stools, confusion, or swelling of the stomach area.

Do not take VIEKIRA XR if you:

  • have certain liver problems
  • take any of the following medicines: alfuzosin hydrochloride (Uroxatral®) • carbamazepine (Carbatrol®, Epitol®, Equetro®, Tegretol®, TEGRETOL®-XR, TERIL®) • cisapride (Propulsid®) • colchicine (Colcrys®), in patients who have certain kidney or liver problems • dronedarone (Multaq®) • efavirenz (Atripla®, Sustiva®) • ergot-containing medicines, including ergotamine tartrate (Cafergot®, Ergomar®, Ergostat®, Medihaler®, Migergot®, Wigraine®, Wigrettes®), dihydroergotamine mesylate (D.H.E. 45®, Migranal®), methylergonovine (Ergotrate®, Methergine®) • ethinyl estradiol-containing medicines • gemfibrozil (Lopid®) • lovastatin (Advicor®, Altoprev®, Mevacor®) • lurasidone (Latuda®) • midazolam (when taken by mouth) • phenytoin (Dilantin®, Phenytek®) • phenobarbital (Luminal®) • pimozide (Orap®) • ranolazine (Ranexa®) • rifampin (Rifadin®, Rifamate®, Rifater®, Rimactane®) • sildenafil citrate (Revatio®), when taken for pulmonary artery hypertension (PAH) • simvastatin (Simcor®, Vytorin®, Zocor®) • St. John’s wort (Hypericum perforatum) or a product that contains St. John’s wort • triazolam (Halcion®)
  • have had a severe skin rash after taking ritonavir (Norvir®)

What should I tell my doctor before taking VIEKIRA XR?

  • If you have: liver problems other than hep C infection, HIV infection, or any other medical conditions.
  • If you have had a liver transplant. If you take the medicines tacrolimus (Prograf®) or cyclosporine (Gengraf®, Neoral®, Sandimmune®), your doctor should check your blood levels and, if needed, may change your dose of these medicines or how often you take them, both during and after treatment with VIEKIRA XR.
  • If you are pregnant or plan to become pregnant or if you are breastfeeding or plan to breastfeed. It is not known if VIEKIRA XR will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take VIEKIRA XR.
  • About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with VIEKIRA XR.
    • Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take VIEKIRA XR with other medicines.
    • When you are finished with VIEKIRA XR, ask your doctor what to do if you had a change in dose or stopped one of your usual medicines during VIEKIRA XR treatment.

What are the common side effects of VIEKIRA XR?

  • For VIEKIRA XR used with ribavirin, side effects include tiredness, nausea, itching, skin reactions such as redness or rash, sleep problems, and feeling weak.
  • For VIEKIRA XR used without ribavirin, side effects include nausea, itching, and sleep problems.

These are not all of the possible side effects of VIEKIRA XR. Tell your doctor if you have any side effect that bothers you or that does not go away.

This is the most important information to know about VIEKIRA XR. For more information, talk to your doctor or healthcare provider.


USE

VIEKIRA XR (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets is a prescription medicine used with or without ribavirin to treat adults with genotype 1 chronic (lasting a long time) hepatitis C (hep C) virus infection.

VIEKIRA XR can be used in people who have compensated cirrhosis.

VIEKIRA XR is not for people with advanced cirrhosis (decompensated). If you have cirrhosis, talk to your doctor before taking VIEKIRA XR.


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including the Medication Guide.

If you cannot afford your medication, contact www.pparx.org for assistance.

VIEKIRA XR and NORVIR are trademarks of AbbVie Inc. All other brands listed are trademarks of their respective owners and are not trademarks of AbbVie Inc. The makers of these brands are not affiliated with and do not endorse AbbVie Inc. or its products.




You are leaving VIEKIRA.com.

You are leaving the AbbVie Web site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site’s endorsement of VIEKIRA.com or AbbVie.

Do you wish to leave this site?

Thank you.

A proCeed Advisor will contact you within 24 hours.

Terms and Conditions

AbbVie is providing this service to help patients find doctors in their area.

No fees have been received by or paid to doctors for participating in this locator service. Inclusion of any physician in this directory does not represent an endorsement by or recommendation from AbbVie.

You are ultimately responsible for the selection of a physician and it is an important decision that you should consider carefully. This doctor locator tool is just one source of information available to you.

OK